Please urgently contact your two Senators and urge them to sign a letter circulating in the Senate to protect the Avastin women. Please click here to read the letter
. This is one of our last hopes to influence FDA Commissioner Hamburg, who will make the final decision on Avastin probably within the next month.
Attached you will find the letter Senator Wicker is circulating around the Senate. Please contact your Senators, and ask them to contact Wesley Clay on Senator Wicker's staff to sign the letter. He can be reached at firstname.lastname@example.org
or (202) 224-6253.
Please click on the link below, find your State on the map, click on it and then you will see the contact information for your two Senators.
You can call or you can e-mail. E-mail may be best. Here is the outline of the text that you can use in an e-mail to your Senators:
A recent Food and Drug Administration (FDA) panel recommended the withdrawal of the cancer drug Avastin. Initially approved by the FDA, Avastin has been vital to many in the treatment of metastatic cancer and has produced significant benefits for some patients on the medication. Please call on Commissioner Hamburg to consider the lives of your constituents who value extended life during their quest to fight breast cancer and allow Avastin to remain an option for treatment.
While drug safety is an important consideration, patients taking Avastin are running out of time and options for treatment. Decisions on patient treatment for this serious disease should be made between patients and their doctors. Until a cure is developed or other successful treatment alternatives are available, patients with metastatic breast cancer should be given the option of taking Avastin.
FDA Commissioner Margaret Hamburg is expected to make the final in the coming weeks. A letter from your office will ensure your constituents' concerns are heard.